Friday, October 9, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AHugel chases 1 trillion won in three yearsyesterdaySearch DemandMedical Spa Revenue Calculator: Model Your Practice Economics6 weeks agoBusiness & M&AAbbVie takes $216M charge on Q3 deals, cuts earnings3 days agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure Requirements6 weeks agoDevices & TechDEKA and GeoMedics expand laser portfolio across India4 days agoBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift5 weeks agoDevices & TechBTL expands EXOMIND brain stimulation to OCD, adolescentslast weekDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)4 weeks agoDevices & TechSkinHealth Systems launches SkinStylus in six European marketslast weekDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance4 weeks agoRegulatoryAllergan gets Health Canada nod for Boey, a fast-acting short-duration toxinlast weekDevices & TechECHOLASER X4 Clears FDA 510(k) for General Surgery3 weeks ago
Sun Protection

Avobenzone

Broad-spectrum UVA absorber; degrades under sun exposure.

Also known as: Butyl methoxydibenzoylmethane, 1-(4-methoxyphenyl)-3-(4-tert-butylphenyl)propane-1,3-dione, Parsol 1789

What it is
Avobenzone is a lipophilic (oil-soluble) organic UV filter that absorbs UVA radiation, particularly in the UVA-I range (340–400 nm). It is one of the few approved broad-spectrum UVA absorbers in sunscreen formulations.
What it does
Avobenzone absorbs UVA rays and converts them into heat, protecting skin from photodamage, premature aging, and skin cancer risk. However, it is photounstable—it degrades when exposed to sunlight—reducing its protective efficacy over time unless stabilized by other ingredients or frequent reapplication.
The evidence
Strong clinical evidence supports avobenzone's UVA absorption and photoprotection. Moderate evidence shows it degrades significantly within 30–60 minutes of sun exposure; stabilizers (e.g., octocrylene, avobenzone-stabilizing polymers) improve photostability. It is FDA-approved and widely used in broad-spectrum sunscreens.
Best for
All skin types requiring UVA protection; essential for photosensitive individuals, those with melasma or post-inflammatory hyperpigmentation, and anyone seeking broad-spectrum (UVA + UVB) coverage.
Pairs well with
Octocrylene, titanium dioxide, zinc oxide, octinoxate, and avobenzone-stabilizing agents (e.g., Helioplex, Mexoryl SX) to enhance photostability and broad-spectrum protection.
Use cautiously with
Avoid pairing with unstabilized formulations or products prone to separation; avobenzone can interact with certain preservatives or chelating agents if not properly formulated. Reapply frequently (every 2 hours) as it degrades in sunlight.
Cautions
Avobenzone is photounstable and loses efficacy with sun exposure; reapplication is critical. Rare contact sensitization reported in sensitive individuals. Not recommended as the sole UVA filter without stabilizers. Pregnancy: generally recognized as safe, but consult a healthcare provider if concerned.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Get the free brief
Inside MedSpa · Free brief

By the time it's news, it's too late.

FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
FDA, recalls and rule changes for practice owners Get the free brief →